CHARLES BROWN, Director, Global Pricing and Contracting, Global Value & Access, Novartis Gene Therapies

Charles joined the Novartis Gene Therapies in 2021, as global director of pricing and contracting, leading access for patients with spinal muscalar atrophy. Previously, Charles  headed pricing and access capabilities with the Global Novartis Oncology team, moving from Canada to the New Jersey Campus of Novartis Oncology.  In this role, Charles led pricing and access strategies that have improved patient access to Novartis Oncology brands in Canada and Latin America. Before moving to the US, Charles was a member of the Canadian Novartis Oncology Value & Access team.  In this role, Charles was driven to ensure oncology patients have access to the right medicine at the right time.

Charles has over 25 years of experience in the pharmaceutical Industry. He has also held positions in Canada as Health Policy and Patient Access Manager, Director of sales, Product Manager, and Manager for New Product Development.

Charles has a Bachelor of Arts in Economics from Simon Fraser University, as well as a Master of Business Administration from Royal Roads University, both in British Columbia, Canada.   Charles enjoys reading and has a passion for rugby, cycling and travel.